title: Genotypic and functional properties of early infant HIV-1 envelopes.
abstract: BACKGROUND
  Understanding the properties of HIV-1 variants that are transmitted from women to their infants is crucial to improving strategies to prevent transmission. In this study, 162 full-length envelope (env) clones were generated from plasma RNA obtained from 5 HIV-1 Clade B infected mother-infant pairs. Following extensive genotypic and phylogenetic analyses, 35 representative clones were selected for functional studies.
  
  
  RESULTS
  Infant quasispecies were highly homogeneous and generally represented minor maternal variants, consistent with transmission across a selective bottleneck. Infant clones did not differ from the maternal in env length, or glycosylation. All infant variants utilized the CCR5 co-receptor, but were not macrophage tropic. Relatively high levels (IC₅₀ ≥ 100 μg/ml) of autologous maternal plasma IgG were required to neutralize maternal and infant viruses; however, all infant viruses were neutralized by pooled sera from HIV-1 infected individuals, implying that they were not inherently neutralization-resistant. All infant viruses were sensitive to the HIV-1 entry inhibitors Enfuvirtide and soluble CD4; none were resistant to Maraviroc. Sensitivity to human monoclonal antibodies 4E10, 2F5, b12 and 2G12 varied.
  
  
  CONCLUSIONS
  This study provides extensive characterization of the genotypic and functional properties of HIV-1 env shortly after transmission. We present the first detailed comparisons of the macrophage tropism of infant and maternal env variants and their sensitivity to Maraviroc, the only CCR5 antagonist approved for therapeutic use. These findings may have implications for improving approaches to prevent mother-to-child HIV-1 transmission.
authors.affiliation: Graduate School of Biomedical Sciences, University of Massachusetts Medical School, Worcester, MA, USA.
authors.forename: Michael
authors.initials: M
authors.lastname: Kishko
authors.forename: Mohan
authors.initials: M
authors.lastname: Somasundaran
authors.forename: Frank
authors.initials: F
authors.lastname: Brewster
authors.forename: John L
authors.initials: JL
authors.lastname: Sullivan
authors.forename: Paul R
authors.initials: PR
authors.lastname: Clapham
authors.forename: Katherine
authors.initials: K
authors.lastname: Luzuriaga
mesh_terms: D000328:Adult; D005260:Female; D015658:HIV Infections / Q000276:immunology / Q000635:transmission / Q000821:virology*; D015497:HIV-1 / Q000145:classification / Q000235:genetics* / Q000302:isolation & purification / Q000378:metabolism; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000276:immunology / Q000821:virology*; D018445:Infectious Disease Transmission, Vertical; D008297:Male; D008969:Molecular Sequence Data; D010802:Phylogeny; D019713:Receptors, CCR5 / Q000276:immunology; D054299:env Gene Products, Human Immunodeficiency Virus / Q000235:genetics* / Q000378:metabolism*
chemical_list: D019713:Receptors, CCR5; D054299:env Gene Products, Human Immunodeficiency Virus